Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lithium cation
Drug ID BADD_D01304
Description Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also be used to augment other antidepressant drugs. It is also sometimes prescribed as a preventive treatment for migraine disease and cluster headaches. The active principle in these salts is the lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of its greater charge, occupying their sites in several critical neuronal enzymes and neurotransmitter receptors.
Indications and Usage Lithium, in its salt forms, is used as a mood stabilizer and for the treatment of depression and mania. It is most frequently prescribed in the treatment of bipolar disorder.
Marketing Status experimental
ATC Code N05AN01
DrugBank ID DB01356
KEGG ID D08133
MeSH ID D008094
PubChem ID 28486
TTD Drug ID D5MF8Y
NDC Product Code Not Available
UNII 8H8Z5UER66
Synonyms Lithium | Lithium-7 | Lithium 7
Chemical Information
Molecular Formula Li+
CAS Registry Number 17341-24-1
SMILES [Li+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Acanthosis nigricans23.01.04.001; 16.32.01.0030.000653%Not Available
Aggression19.05.01.0010.000672%Not Available
Agitation19.06.02.001; 17.02.05.0120.002439%
Akathisia17.01.02.002; 19.06.02.0060.000710%
Albuminuria20.02.01.001--Not Available
Alopecia23.02.02.001--
Altered state of consciousness19.07.01.003; 17.02.04.0010.000768%Not Available
Amnesia19.20.01.001; 17.03.02.0010.000384%
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001--Not Available
Aphasia19.21.01.001; 17.02.03.0010.001248%
Arrhythmia02.03.02.0010.000576%Not Available
Arteriospasm coronary12.02.01.031; 24.04.04.005; 02.02.02.0050.000192%Not Available
Arthralgia15.01.02.001--
Asthenia08.01.01.0010.002477%Not Available
Ataxia17.02.02.001; 08.01.02.0040.002304%
Atrioventricular block02.03.01.0020.000576%Not Available
Atrioventricular block complete02.03.01.0030.000288%
Atrioventricular block first degree02.03.01.0040.000288%
Blindness06.02.10.003; 17.17.01.003--Not Available
Blood creatinine decreased13.13.01.003--Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.0020.001383%Not Available
Bundle branch block right02.03.01.0110.000288%Not Available
Cardiac arrest02.03.04.0010.001056%
Cardiac hypertrophy02.04.02.0170.000192%Not Available
Cardio-respiratory arrest02.03.04.002; 22.02.06.0070.000384%Not Available
Cardiogenic shock24.06.02.006; 02.05.01.0030.000192%Not Available
Catatonia19.11.01.0010.000192%Not Available
Cerebellar atrophy17.11.01.0080.000384%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 11 Pages